Nick Desai is cofounder and CEO of Heal.
A deal with Sandoz to lead the global launch of Pear's two lead products puts marketing muscle behind the nascent class of 'prescription digital therapeutics.'
In the absence of behemoths such as Facebook and Twitter, pharma is partnering with China's tech giants to snare a slice of a more than $100 billion market
The CEO's experience launching medical reference app Epocrates led him to found a social network for physicians.
Consumers younger than the age of 45 were most likely to use an app developed by their health plan.
The FDA-approved app will allow MS patients to share their medication injection history with HCPs.
The drugmaker saw a gap in patient-physician conversation about retinal disease.
He instead decided to find a way to make a physician's job easier by creating a clinical messaging platform.
A bout with Lyme disease led Yee to found a company that helps patients measure and track their breathing patterns.
The connection to Pristiq is not overt in the app's user interface, though Moodivator is featured on Pristiq's website.
Companies such as Eli Lilly and Medtronic have launched branded apps for their products, but experts say they don't make sense for all medicines.
The app's co-founder discusses how it's educating patients and physicians about artificial intelligence and why Cardiogram is different from other heart-rate tracking apps.
The motivating force behind My GI Health met initial resistance. After all, it came from a company executive who professed that his goal was to benefit all companies within that therapeutic area.
Merck settles a marketing lawsuit for $5.9 million; CVS plans to create diagnostic apps; a survey shows advertising agencies plan to keep head count steady for the rest of the year
We know it's early days (the smartwatch been available for three days to be exact), but we'd like to know how it is going.
Apple is putting the power of clinical trials in our pockets with ResearchKit.
The small screen makes it a user-friendly medication adherence tool.
The app for the smartwatch includes secure encrypted messaging.
The open-source framework uses the iPhone's apps to gather users' health information.
Phunware's VP Product Evangelist will explore how hospitals can implement a wayfinding and messaging solution, and how they can expect to benefit from it.
FDA draws fine line between health and wellness apps; Colorado gives biosimilar swap law another look; ZMapp is set to start human trials of its Ebola vaccine.
United Healthcare's Baby Blocks app seeks to become all-in-one hub for expectant moms and their babies.
Researchers say the iPad app could help assess vision loss.
The health and lifestyle resource's latest app seeks to provide context for all that biometric data consumers are storing in wearables, wireless scales and glucometers.
The bedside decision-making app includes clinical trial and drug information as well as breaking news.
The maker of an FDA-approved app says its algorithm can use images to assess surgery-related blood loss.
TapTrak seeks to apply behavioral tracking to clinical trials.
The agency issued final guidance on mobile apps, saying it will focus only on a subset that present the greatest risk to patients if they don't work correctly.
FDA is concerned state biosimilar legislation could make consumers uneasy about the category, J&J hands $75 million milestone payment for ibrutinib, Consumer Reports gets into drug apps
Patient use of the professional app prompted the latest iteration, and the foundation behind it is set to launch a media push.